Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865264 · ClinicalTrials.gov registry record · NA
Living Organ Donor Recovery Enhancement Program
A NA study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03865264 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 21 participants.
The verdict
NCT03865264, a NA study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.
Interventions
- OTHER Recovery Enhancement Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2024-01-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03865264
The ClinicalTrials.gov registry entry for NCT03865264 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Recovery Enhancement Program is the first listed.
NCT03865264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03865264 about?
NCT03865264 is a clinical study titled "Living Organ Donor Recovery Enhancement Program". The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.
What is the current status of trial NCT03865264?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2017-04-20. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT03865264?
The interventions under investigation include: Recovery Enhancement Program (OTHER).
Who is sponsoring clinical trial NCT03865264?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.